Shingrix Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

After reconstitution, one dose (0.5 ml) contains: Varicella Zoster Virus¹ glycoprotein E antigen^2,3 50 micrograms.
¹ Varicella Zoster Virus = VZV.
² adjuvanted with AS01_B containing: plant extract Quillaja saponaria Molina, fraction 21 (QS-21) 50 micrograms; 3-O-desacyl-4'-monophosphoryl lipid A (MPL) from Salmonella minnesota 50 micrograms.
³ glycoprotein E (gE) produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology.
Excipients/Inactive Ingredients: Powder (gE antigen): Sucrose, Polysorbate 80 (E 433), Sodium dihydrogen phosphate dihydrate (E 339), Dipotassium phosphate (E 340).
Suspension (AS01_B Adjuvant System): Dioleoyl phosphatidylcholine (E 322), Cholesterol, Sodium chloride, Disodium phosphate anhydrous (E 339), Potassium dihydrogen phosphate (E 340), Water for injections.

recombinant varicella-zoster virus glycoprotein e antigen vaccine

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig